Content » Vol 93, Issue 6


Acne: Risk Indicator for Increased Body Mass Index and Insulin Resistance

Bodo C. MELNIK1, Swen Malte JOHN1 and Gerd PLEWIG2

1Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, and 2Clinic and Policlinic for Dermatology and Allergology, University of Munich, Munich, Germany

Acne appears to represent a visible indicator disease of over-activated mTORC1 signalling, an unfavour­able metabolic deviation on the road to serious common Western diseases of civilisation associated with increased body mass index and insulin resistance. Exaggerated mTORC1 signalling by Western diet explains the association of acne with increased body mass index, insulin resistance, and early onset of menarche. Both, a high glycaemic load and increased consumption of milk and milk products, staples of Western diet, aggravate mTORC1 signalling. This review of the literature summarises present evidence for an association between acne, increased body mass index, insulin resistance and Western diet. By dietary intervention with a Palaeolithic-type diet, the dermatologist has the chance to attenuate patients’ increased mTORC1 signalling by reducing glycaemic load and milk consumption, which may not only improve acne but may delay the march to more serious mTORC1-driven diseases of civilisation. Key words: acne, body mass index, glycaemic load, insulin resistance, milk consumption, mTORC1

Accepted May 22, 2013; Epub ahead of print Aug 8, 2013

Acta Derm Venereol

Bodo C. Melnik, MD, Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Sedanstrasse 115, DE-49090 Osnabrück, Germany. E-mail:

Kwon et al. (1) recently demonstrated in this journal that a low glycaemic load (GL) diet had beneficial effects in the treatment of acne. High GL is a characteristic feature of Western diet, which is frequently associated with increased body mass index (BMI) and increased body fat composition. Dietary glycaemic index (GI) and GL were positively associated with body fatness among Danish boys aged 16 years (2). These observations already point to an association between acne and increased BMI. Accumulating evidence underlines the role of Western diet in the pathogenesis of acne. Two major compounds of Western diet have been identified to drive acne pathogenesis: (i) hyperglycaemic carbohydrates (high GL) and (ii) insulinotropic milk/dairy products, both promoting increased insulin/insulin-like growth factor-1 (IGF-1) signalling (3–6). High BMI is obviously the clinical correlate of a high anabolic state of metabolism. The first epidemiological evidence for an association between milk consumption and acne has been presented by the retrospective evaluation of 47,355 US women participating in the Nurses’ Health Study II (NHSII) (7). Two following prospective epidemiological studies confirmed the milk-acne relationship in the Growing Up Today Study with 6,094 girls (8) and 4,273 boys (9), who are the offspring of the mothers of the NHSII.


Intriguingly, Berkey et al. (10) followed 12,829 children of the Growing Up Today Study and found an association between milk consumption and weight gain expressed as an increase of body mass index (BMI). These results of the Growing Up Today Study pointing to a milk-acne and milk-BMI relationship thus imply the possibility of an acne-BMI relationship (Fig. 1). In fact, Di Landro et al. (11) have recently reported that acne risk was reduced in Italian adolescents and young adults with lower BMI. Accordingly, a lower BMI has been associated with lower acne prevalence in Taiwanese boys and girls (12). In contrast, Halvorsen et al. (13) observed an association between increased BMI and acne in female Norwegian adolescents. Furthermore, British male soldiers older than 20 years with acne have been reported to be heavier than those with­out acne (14). Del Prete et al. (15) recently provided evidence that young Italian males affected with acne had a high BMI and exhibited insulin resistance. Thus, substantial worldwide evidence appears to support an acne-BMI relationship (11–15). High BMI is a major factor of the metabolic syndrome, which is associated with insulin resistance and represents the typical feature of metabolic diseases of Western civilisation. Indeed, Cordain et al. (3) have suggested that acne belongs to the family of diseases of Western civilisation like obesity, type 2 diabetes mellitus and cancer.

Fig. 1. Relationship between high milk consumption/high glycaemic load (GL) and acne as well as increased body mass index (BMI). High GL and milk activate mTORC1 signalling.



At the cellular level, nutrient, amino acid as well as insulin-/IGF-1 availability are sensed by the nutrient-sensitive kinase mammalian target of rapamycin complex 1 (mTORC1), the central cellular regulator promoting protein- and lipid synthesis, cell growth and proliferation (16). From all amino acids, the branched-chain amino acid (BCAA) leucine plays a crucial role for mTORC1 activation (16, 17). Not by chance, milk provides highest amounts of leucine in comparison to all other animal proteins to optimise mTORC1 activation for postnatal growth. Several recent metabolomics studies underline the relationship between high plasma BCAA profiles, increased BMI and insulin resistance recently reviewed by Morris et al. (18). Thus, acne appears to develop in a metabolic environment with increased mTORC1 signalling and has been proposed to represent a visible mTORC1-driven disease of civilisation (19). In this regard, acne appears to feature over-stimulated mTORC1 signalling affecting the sebaceous follicle aggravated by nutrient signals derived from Western diet (6, 19).


Milk has been identified as a promoter of mTORC1-mediated anabolic endocrine signalling created for the stimulation of postnatal growth in mammals (19). Thus, milk is not “just food” but functions as an endocrine relay system enhancing postnatal mTORC1 signalling comparable to enhanced IGF-1/mTORC1 signalling promoting pubertal growth (Fig. 2) (19). Milk protein consumption increases plasma levels of highly insulinotropic BCAAs (leucine, isoleucine and valine) resulting in postprandial hyperinsulinaemia and persistently elevated plasma levels of IGF-1, thus providing pivotal signals for mTORC1 activation (19). First evidence supporting a correlation between milk consumption and BMI has been provided by the Growing Up Today Study (10). Further support comes from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2004, which demonstrated that higher BMI percentiles among US White, Black, and Mexican-American children of age 2–4 years was associated with increased milk consumption (20). In accordance, Di Landro et al. (11) recently provided clinical evidence that acne risk increased with the frequency of milk consumption of adolescents. Remarkably, Arnberg et al. (21) reported that milk protein consumption (either daily intake of 35 g of whey, casein or skim milk protein) further increased BMI and C-peptide plasma levels in overweight Danish adolescents.


Fig. 2. Western diet composed of high glycaemic load and increased high milk/dairy protein consumption containing abundant amounts of branched-chain amino acids (BCAAs) both over-stimulate mTORC1-S6K1 signalling promoting exaggerated cell growth and proliferation as well as S6K1-mediated insulin resistance. GIP=glucose-dependent insulinotropic polypeptide; GH=growth hormone; GHR=GH receptor; IGF-1=insulin-like growth factor-1, LAT=L-type amino acid transporter; IR=insulin receptor; IGF1R=IGF-1 receptor; IRS1=insulin receptor substrate-1; PI3K=phosphoinositol-3 kinase; Akt=Akt kinase (protein kinase B); TSC=tuberous sclerosis complex; Rheb=ras-homologue enriched in brain; mTORC1=mammalian (mechanistic) target of rapamycin complex 1; 4E-BP-1= 4E-binding protein 1; S6K1= S6 kinase 1.


Elevated plasma concentrations of BCAAs leucine, isoleucine and valine, major constituents of milk proteins and pivotal activators of the amino acid-sensitive enzyme mTORC1, have been associated with obesity and future insulin resistance in children and adolescents in the United States (22). There is accumulating evidence that high plasma levels of BCAAs are associated with insulin resistance (18). In fact, Hoppe et al. (23) have demonstrated that high intake of milk protein (53 g/day), but not meat (53 g/day) increased basal insulin serum levels and induced insulin resistance in 8-year-old Danish boys.

Thus, enhanced mTORC1 signalling results from high GL and milk consumption, which both play a fundamental role in the pathogenesis of food-aggravated acne. Exaggerated mTORC1 signalling induced by Western diet stimulates the important downstream target of mTORC1, the kinase S6K1, which negatively controls insulin signalling at the level of insulin receptor substrate-1 (IRS-1) phosphorylation (6, 19). Nutrient-mediated over-stimulation of mTORC1-S6K1-signalling thus induces insulin resistance, the characteristic feature of high milk consumption, acne and conditions associated with the metabolic syndrome (Fig. 2) (18–23).


The NHANES study also confirmed that increased milk consumption in children was related to an early onset of menarche (24). Remarkably, more severe comedonal acne has been associated with an earlier onset of menarche (25). Thus, increased milk and milk protein consumption is not only associated with acne (5–9, 11, 26–28) but also with early onset of menarche (24, 25). It is of most critical concern that early onset of menarche has recently been related to an increased risk of obesity, type 2 diabetes mellitus and metabolic syndrome in adult life (29–34). Thus, an appropriate endocrine, metabolic and growth balance during puberty and adolescence appears to be of critical importance for health in adulthood.


A frequent history of more severe acne appears to be related to a higher prevalence of prostate cancer later in life (35, 36). The growth-promoting signalling system of milk may not only over-activate mTORC1-driven growth of sebaceous glands but may also affect mTORC1-mediated prostate morphogenesis and maturation during puberty (37). There is convincing evidence from molecular oncology that increased mTORC1 signalling steers cancer initiation and metastasis (38). It is thus of concern that epidemiological evidence from Island emphasised an association between daily milk consumption during adolescence and increased risk for advanced prostate cancer later in life (39). Again, the time of puberty, which is associated with the highest incidence of acne, appears to be a most sensitive period affecting long-term prostatic tissue homeostasis (37).


Western diet, the maximised form of Neolithic nutrition, with highly over-activated mTORC1-signalling appears to promote a special human phenotype, the “milk giant” characterised by increased linear growth (40), increased BMI, obesity (10, 20, 21), frequent juvenile-onset myopia (increased vitreal chamber growth) (41), insulin resistance (23), type 2 diabetes and cancer (37, 42–44). This “maximised” growth phenotype exhibits a high prevalence of acne, a proposed indicator of exaggerated mTORC1-signalling. In contrast, humans like the Kitava islanders, who consume a Palaeolithic diet without grains and milk products apparently live on a normal insulin/IGF-1/mTORC1-axis, exhibit normal BMI, are insulin-sensitive, have very low prevalence rates of diseases of civilisation and do not exhibit acne, not even during their climax of puberty (3, 45–47). In comparison to the Kitava, untreated subjects with Laron dwarfism, who exhibit a genetic growth hormone receptor defect with congenital IGF-1 deficiency and thus abnormally decreased mTORC1 signalling are of short stature, but most importantly are protected against the epidemics of type 2 diabetes, cancer and acne (48–51). In patients with Laron syndrome the somatotropic axis is pathologically low. In humans consuming a Palaeolithic diet the somatotropic axis appears to in the normal range, whereas regular milk and dairy consumers exhibit an increased somatotropic axis with enhanced plasma levels of growth hormone and 20–30% increased IGF-1 levels compared to non-dairy consumers (52–57). IGF-1, the central growth hormone of puberty, is the most important stimulus for mTORC1-driven sebaceous gland growth and lipogenesis (58, 59). IGF-1 via mTORC1 activation up-regulates the activity of sterol response element binding protein-1 (SREBP-1), the key transcription factor of lipogenesis (60–62), as well as IGF-1/FoxO1-mediated up-regulation of androgen receptor signal transduction, which co-stimulates sebaceous lipogenesis (63–65).

Thus, the absence of acne in untreated Laron syndrome with low IGF-1/mTORC1 signalling, the absence of acne in Kitava islanders consuming Palaeolithic diet (no milk, no grains) with normal body shape and obviously normal mTORC1 activity, but epidemic acne in populations consuming Western diet, where milk/dairy intake and glycaemic load are abundant lead to over-activated mTORC1 signalling (Figs 2 and 3).


Acne appears to be a visible indicator of systemically exaggerated mTORC1 signalling, an unfavourable metabolic deviation on the road to serious mTORC1-driven diseases of civilisation, especially overweight (increased BMI), obesity, arterial hypertension, insulin resistance, type 2 diabetes mellitus, cancer, and Alzheimer´s disease (42–44, 66–68). Increased milk consumption during adolescence may not only negatively affect sebaceous gland homeostasis but may exert long-term adverse health effects on other glands like the prostate. Epidemic acne is thus not a bagatelle but a constellation of exaggerated mTORC1 signalling, a metabolic deviation enhancing the risk for serious diseases of civilisation. During adolescence exaggerated mTORC1 signalling may not only affect sebaceous follicle homeostasis but may disturb normal sexual maturation and mTORC1-dependent morphogenesis (Fig. 3).


Fig. 3. Acne: a risk indicator of increased mTORC1 signalling on the march to chronic diseases of civilisation. Potential impact of dermatologic treatment for dietary prevention of acne and chronic diseases of civilisation by attenuating increased mTORC1 signalling.

The role of high GL and milk consumption in the pathogenesis of acne has reached highest academic interest in the field of nutritional sciences and dermatology (69). Therefore, more clinical placebo-controlled randomised intervention studies with special attention to combinations of high GL and milk/dairy consumption are required. Dermatologists should not only focus on the treatment of acne´s skin pathology, but should appreciate the underlying systemic effects of over-stimulated mTORC1 signalling induced by high GL and increased consumption of milk and milk products. The dermatologist, frequently involved in the treatment of adolescents during a vulnerable phase of metabolic programming, may not solely focus on treating acne´s skin pathology but should appreciate the great chance for dietary intervention. Dietary attenuation of over-stimulated mTORC1 signalling may not only improve acne but may prevent the march to more serious chronic mTORC1-driven diseases of civilisation. In this regard, most common acne vulgaris of adolescents of industrialised countries is not a “physiological” phenomenon of puberty, but represents a visible risk indicator already pointing to aberrant nutrient signalling promoting chronic epidemic diseases of civilisation.

The authors declare no conflict of interest.


1. Kwon HH, Youn JY, Hong JS, Jung JY, Park MS, Suh DH. The clinical and histological effect of low glycaemic load diet in the treatment of acne vulgaris in Korean patients: a randomized, controlled trial. Acta Derm Venereol 2012; 92: 241–246.

2. Nielsen BM, Bjørnsbo KS, Tetens I, Heitmann BL. Dietary glycaemic index and glycaemic load in Danish children in relation to body fatness. Br J Nutr 2005; 94: 992–997.

3. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138: 1584–1590.

4. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247–256.

5. Melnik BC. Evidence for acne-promoting effects of milk and other insulinotropic dairy products. Nestle Nutr Workshop Ser Pediatr Program 2011; 67: 131–145.

6. Melnik BC. Diet in acne: Further evidence for the role of nutrient signalling in acne pathogenesis. Acta Derm Venereol 2012; 92: 228–231.

7. Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD. High school dietary intake and acne. J Am Acad Dermatol 2005; 52: 207–211.

8. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al. Milk consumption and acne in adolescent girls. Dermatol Online J 2006; 12: 1.

9. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008; 58: 787–793.

10. Berkey CS, Rockett HH, Willett WC, Colditz GA. Milk, dairy fat, dietary calcium, and weight gain. Arch Pediatr Adolesc Med 2005; 159: 543–550.

11. Di Landro A, Cazzaniga S, Parazzini F, Ingordo V, Cusano F, Atzori L, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012; 67: 1129–1135.

12. Tsai MC, Chen WC, Cheng YW, Chen GY, Hsu TJ. Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol 2006; 16: 251–253.

13. Halvorsen JA, Vleugels RA, Bjertness E, Lien L. A population-based study of acne and body mass index in adolescents. Arch Dermatol 2012; 148: 131–132.

14. Bourne S, Jacobs A. Observations on acne, seborrhoea, and obesity. Br Med J 1956; 1: 1268–1270.

15. Del Prete M, Mauriello MC, Faggiano A, Di Somma C, Monfrecola G, Fabbrocini G, Colao A. Insulin resistance and acne: a new risk factor for men? Enodcrine 2012; 42: 555–560.

16. Dodd KM, Tee AR. Leucine and mTORC1: a complex relationship. Am J Physiol Endocrinol Metab 2012; 302: E1329–E1342.

17. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21–35.

18. Morris C, O´Grada C, Ryan M, Roche HM, Gibney MJ, Gibney ER, Brennan L. The relationship between BMI and metabolomics profiles: a focus on amino acids. Proceed Nutr Soc 2012; 71: 634–638.

19. Melnik B. Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol 2012; 4: 20–32.

20. Wiley AS. Dairy and milk consumption and child growth: is BMI involved? An analysis of NHANES 1999–2004. Am J Hum Biol 2010; 22: 517–525.

21. Arnberg K, Mølgaard C, Michaelsen KF, Jensen SM, Trolle E, Larnkjær A. Skim milk, whey, and casein increase body weight and whey and casein increase the plasma C-peptide concentration in overweight adolescents. J Nutr 2012; 142: 2083–2090.

22. McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, et al. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes 2012; 8: 52–61.

23. Hoppe C, Molgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 2005; 59: 393–398.

24. Wiley AS. Milk intake and total dairy consumption: associations with early menarche in NHANES 1999–2004. PLoS One 2011; 6: e14685.

25. Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997; 130: 30–39.

26. Ismail NH, Abdul Manaf Z, Azizan NZ. High glycemic load, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study. BMC Dermatol 2012; 12: 13.

27. Silverberg NB. Whey protein precipitating moderate to severe acne flares in 5 teenaged athlethes. Cutis 2012; 90: 70–72.

28. Simonart T. Acne and whey protein supplementation among bodybuilders. Dermatology 2012; 225: 256–258.

29. Mendoza N, Galliano D, Salamanca A, Castro JE, Mozas J, Sánchez-Borrego R, et al. Lowering the age at menarche and risk of early menarche in a population of Spanish postmenopausal women during the past two decades. Menopause Int 2010; 16: 111–114.

30. Chen L, Zhang C, Yeung E, Ye A, Mumford SL, Wactawski-Wende J, Schisterman EF. Age at menarche and metabolic markers for type 2 diabetes in premenopausal women: the BioCycle Study. J Clin Endocrinol Metab 2011; 96: E1007–E1012.

31. Pierce MB, Kuh D, Hardy R. The role of BMI across the life course in the relationship between age at menarche and diabetes, in a British Birth Cohort. Diabet Med 2012, 29: 600–603.

32. Conway BN, Shu XO, Zhang X, Xiang YB, Cai H, Li H, et al. Age at menarche, the leg length to sitting height ratio, and risk of diabetes in middle-aged and elderly Chinese men and women. PLoS One 2012; 7: e30625.

33. Dreyfus JG, Lutsey PL, Huxley R Pankow JS, Selvin E, Fernández-Rhodes L, et al. Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2012; 55: 2371–2380.

34. Stöckl D, Meisinger C, Peters A Thorand B, Huth C, Heier M, et al. Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study. PLoS One 2011; 6: e26076.

35. Sutcliffe S, Giovannucci E, Isaacs WB, Willett WC, Platz EA. Acne and risk of prostate cancer. Int J Cancer 2007; 121: 2688–2692.

36. Galobardes B, Smith BD, Jeffreys M, Kinra S, McCarron P. Acne in adolescence and cause-specific mortality: Lower coronary heart disease but higher cancer mortality. Am J Epidemiol 2005; 161: 1094–1101.

37. Melnik BC, John SM, Carrera-Bastos P, Cordain L. The impact of cow’s milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond) 2012; 9: 74.

38. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012, 485: 55–61.

39. Torfadottir JE, Steingrimsdottir L, Mucci L Aspelund T, Kasperzyk JL, Olafsson O, et al. Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol 2012; 175: 144–153.

40. Hoppe C, Mølgaard C, Michaelsen KF. Cow’s milk and linear growth in industrialized and developing countries. Annu Rev Nutr 2006; 26: 131–173.

41. Cordain L, Eaton SB, Brand Miller J, Lindeberg S, Jensen C. An evolutionary analysis of the aetiology and pathogenesis of juvenile-onset myopia. Acta Opthalmol Scand 2002; 80: 125–135.

42. Proud CG. mTOR signalling in health and disease. Biochem Soc Trans 2011; 39: 431–436.

43. Melnik BC. Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes 2012; 3: 38–53.

44. Melnik BC. Excessive leucine-mTORC1-signalling of cow milk-based infant formula: the missing link to understand early childhood obesity. J Obes 2012; ID197653.

45. Lindeberg S, Eliasson M, Lindahl B, Ahrén B. Low serum insulin in traditional Pacific Islanders - the Kitava study. Metabolism 1999; 48: 1216–1219.

46. Lindeberg S. Paleolithic diets as a model for prevention and treatment of Western disease. Am J Hum Biol 2012; 24: 110–115.

47. Jönsson T, Ahrén B, Pacini G, Sundler F, Wierup N, Steen S, et al. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond) 2006; 3: 39.

48. Ben-Amitai D, Laron Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. J Eur Acad Dermatol Venereol 2011; 25: 950–954.

49. Melnik BC, John SM, Schmitz G. Over-stimulation of insulin/IGF-1 signaling by Western diet may promote diseases of civilization: lessons learnt from Laron syndrome. Nutr Metab (Lond) 2011; 8: 41.

50. Leslie M. Genetics and disease. Growth defect blocks cancer and diabetes. Science 2011; 331: 837.

51. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med 2011; 3: 70ra13.

52. Hoppe C, Udam TR, Lauritzen L, Mølgaard C, Juul A, Michaelsen KF. Animal protein intake, serum insulin-like growth factor-I, and growth in healthy 2.5-y-old Danish children. Am J Clin Nutr 2004; 80: 447–452.

53. Hoppe C, Mølgaard C, Dalum C, Vaag A, Michaelsen KF. Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys. Eur J Clin Nutr 2009; 63: 1076–1083.

54. Rich-Edwards JW, Ganmaa D, Pollak MN, Nakamoto EK, Kleinman K, Tserendolgor U, et al. Milk consumption and the prepubertal somatotropic axis. Nutr J 2007; 6: 28.

55. Norat T, Dossus L, Rinaldi S, Overvad K, Grønbaek H, Tjønneland A, et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 2007; 61: 91–98.

56. Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2009; 18: 1333–1340.

57. Qin LQ, He K, Xu JY. Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review. Int J Food Sci Nutr 2009; 60 (Suppl 7): 330–340.

58. Smith TM, Cong Z, Gilliland KL, Clawson GA, Thiboutot DM. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 2006; 126: 1226–1232.

59. Smith TM, Gilliland K, Clawson GA, Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol 2008; 128: 1286–1293.

60. Porstmann T, Santos CR, Lewis C, Griffiths B, Schulze A. A new player in the orchestra of cell growth: SREBP activity is regulated by mTORC1 and contributes to the regulation of cell and organ size. Biochem Soc Trans 2009; 37: 278–283.

61. Peterson TR, Sengupta SS, Harris TE Carmack AE, Kang SA, Balderas E, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011; 146: 408–420.

62. Bakan I, Laplante M. Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol 2012; 23: 226–234.

63. Melnik B. Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies. J Dtsch Dermatol Ges 2009; 7: 364–370.

64. Yanase T, Fan W. Modification of androgen receptor function by IGF-1 signaling: implications in the mechanism of refractory prostate carcinoma. Vitam Horm 2009; 80: 651–666.

65. Ma Q, Fu W, Li P, Nicosia SV, Jenster G, Zhang X, Bai W. FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment. Mol Endocrinol 2009; 23: 213–225.

66. Harlan SM, Guo DF, Morgan DA, Fernandes-Santos C, Rahmouni K. Hypothalamic mTORC1 signalling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab 2013; 17: 599–606.

67. Pópulo H, Lopes JM, Soares P. The mTOR signalling pathway in human cancer. Int J Mol Sci 2012; 13: 1886–1918.

68. Oddo S. The role of mTOR signaling in Alzheimer disease. Front Biosci 2012; 4: 941–952.

69. Burris J, Rietkerk WR, Woolf K. Acne: the role of medical nutrition therapy. J Acad Nutr Diet 2013; 113: 416–430.